FMOC-(R)-3-AMINO-4,4-DIPHENYL-BUTYRIC ACID, 98%, 1g

Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)methane, 95.0%, 250mg

Methyl 4-(trifluoromethoxy)benzoate, 97.0%, 25g

Larotrectinib, 97%, 100mg

4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide, 95.0%, 25g

3-(2-pyridinyl)-1H-pyrazol-5-amine dihydrochloride, 95.0%, 1g

1-(benzenesulfonyl)-3-bromo-1H-pyrrole, 95.0%, 5g

2-Amino-5-bromo-4,6-dimethylpyridine, 95.0%, 25g

isoxazolo[3,4-b]pyridine-3-carboxylic acid, 95.0%, 1g

(E)-2-Cyano-pent-2-enoic acid ethyl ester, 95.0%, 5g

2,4,6-Tri-tert-butylphenol, 95.0%, 500g

5-CHLORO-2-METHYL-4-NITROBENZOIC ACID, 95.0%, 1g

3-Fluoro-2-iodochlorobenzene, 95.0%, 500g